BPI and Sepsis: Several attempts to formulate adjunctive treatments aiming to reduce hyperinflammation have been made before, including administration of bactericidal/permeability-increasing protein (52) and anti-lipopolysaccharide (LPS) antibody treatment (53); however, these approaches failed to enhance N. meningitidis sepsis outcome in larger clinical trials (54, 55).